US biopharma firm Questcor has signed a deal to acquire Canadian active pharmaceutical ingredient (API) manufacturer BioVectra for an upfront …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

